| Drug Name: | Ranolazine |
|---|
| Drug Class: | Anti-anginal agent |
|---|
| Mechanism of Action: | - Inhibits late sodium current in cardiac myocytes
- Reduces intracellular calcium overload
- Improves diastolic relaxation
|
|---|
| Use: | - Treatment of chronic angina pectoris
- May be used in combination with other anti-anginal agents
|
|---|
| Side Effects: | - Nausea
- Dizziness
- Headache
- Constipation
- QT prolongation
|
|---|
| Contraindications: | - Hypersensitivity to ranolazine
- Severe hepatic impairment
- Use of strong CYP3A inhibitors
|
|---|
| Specialty: | - Cardiology
- Internal Medicine
|
|---|